Filter Results:
(65)
Show Results For
- All HBS Web
(115)
- News (31)
- Research (65)
- Events (1)
- Multimedia (1)
- Faculty Publications (42)
Show Results For
- All HBS Web
(115)
- News (31)
- Research (65)
- Events (1)
- Multimedia (1)
- Faculty Publications (42)
Sort by
- 04 Sep 2018
- First Look
New Research and Ideas, September 4, 2018
moral imperatives, we study the factors that influence when individuals find solutions that fall outside of the salient options presented. In particular, we study moral insight, or the discovery of solutions, other than selecting one of... View Details
Keywords: Dina Gerdeman
- Research Summary
Overview
In examining the competitive dynamics of R&D strategy, Josh has become particularly interested in how the introduction of new knowledge generated by rivals impacts the direction of R&D efforts. Understanding how new information alters project portfolio decisions is... View Details
- 05 Jul 2006
- Research & Ideas
The Accidental Innovator
Business School, while Devin is professor emeritus from Swarthmore College. Sarah Jane Gilbert: Can you explain what accidental innovation is? What led to your interest in researching this concept? Robert Austin: Historical accounts of many important View Details
Keywords: by Sarah Jane Gilbert
- 22 Aug 2005
- Research & Ideas
The Hard Work of Failure Analysis
the hospital quickly followed their example, finding the idea compelling and practical. In the pharmaceutical industry, about 90 percent of newly developed drugs fail in the experimental stage, and thus drug... View Details
Keywords: by Amy Edmondson & Mark D. Cannon
- 15 Nov 2018
- Book
Can the Global Food Industry Overcome Public Distrust?
JamesBrey Food is the largest segment of the global economy. It is also widely recognized as more critical for human health than any pharmaceutical drug on the planet. But significant changes in the industry are making people lose trust in many institutions involved in... View Details
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
Millennium. "With the whole genome known, the process of drug discovery in the future will involve comprehensively identifying all molecular interactions for a drug." Genetic information should be... View Details
- 13 Jan 2003
- Research & Ideas
Making Biotech Work as a Business
as 1994: That year was known among insiders as "The Year of the Placebo." What The Data Says The good news: One hundred thirty drugs can be traced to biotech, said Pisano. (For purposes of discussion during his presentation, he... View Details
- 25 Apr 2005
- Research & Ideas
New Learning at American Home Products
drug business. They relied, however, on licensing rather than building their own in-house capabilities for drug discovery and commercialization. In the low-tech OTC... View Details
- 02 Jul 2001
- Research & Ideas
Ray A. Goldberg
genome, Goldberg has focused his most recent efforts on explaining the impact of this revolutionary discovery on the agribusiness system. "All industries that deal with living things or organic compounds will have a common language... View Details
- 27 Aug 2008
- Research & Ideas
Creating Leaders for Science-Based Businesses
to know how to get those discoveries into the economy." To achieve that goal, Bowen and others believe that science-based companies require a different kind of leadership. "Since the investment and R&D decisions you make... View Details
- 20 Nov 2006
- Research & Ideas
Open Source Science: A New Model for Innovation
and perhaps even refine them more. There's a growing movement and establishment of nonprofit foundations that are participating in drug discovery efforts. These foundations aren't as concerned about... View Details
Keywords: by Martha Lagace
- 17 Oct 2006
- First Look
First Look: October 17, 2006
its anatomy, which has worked well in other high-tech sectors, can't handle the fundamental challenges facing drug R&D: profound, persistent uncertainty and high risks rooted in the limited knowledge of human biology; the need for the... View Details
Keywords: Sean Silverthorne
- 18 Jun 2001
- Research & Ideas
When In-House Research Isn’t Enough
to intellectual property, it's clear they realize they don't have to own a discovery to profit from it," Chesbrough remarked. Years ago, Xerox's legendary Palo Alto Research Center (PARC) was the source of such major advances as the... View Details
Keywords: by Jim Aisner
- 23 Mar 2010
- First Look
First Look: March 23
Publications "From Visible Harm to Relative Risk: Centralization and Fragmentation of Pharmacovigilance Author: Arthur A. Daemmrich Publication: Chap. 13 in The Fragmentation of U.S. Health Care, Oxford University Press, 2010 Abstract Adverse View Details
Keywords: Martha Lagace
- 01 May 2007
- First Look
First Look: May 1, 2007
countries. Download working paper: http://www.hbs.edu/research/pdf/07-073.pdf Open vs. Integrated Innovation: A Model of Discovery and Confinement Authors:Esteve Almirall and Ramon Casadesus-Masanell Abstract We present a simple formal... View Details
Keywords: Sean Silverthorne
- 27 Sep 2011
- First Look
First Look: September 27
for new products, services, and entire businesses. It may look like innovators are born, not made. But according to Jeffrey Dyer, Hal Gregersen, and Clay Christensen anyone can become more innovative. How? Master the discovery skills that... View Details
Keywords: Sean Silverthorne
- 03 Apr 2007
- First Look
First Look: April 3, 2007
drug discovery organization at Wyeth Pharmaceuticals and focuses on the decisions to: (1) centralize decision-making within drug discovery and... View Details
Keywords: Martha Lagace
- 23 May 2019
- Book
These Entrepreneurs Take a Pragmatic Approach to Solving Social Problems
In 1908, Harvard Business School’s first dean, Edwin Francis Gay, welcomed the School’s inaugural class of 59 students by saying that HBS was challenged with encouraging its students to have the “intellectual respect for business as a profession, with the social... View Details
- 03 Mar 2009
- First Look
First Look: March 3, 2009
Public Interest: Roche & Tamiflu Harvard Business School Case 609-061 The case focuses on the challenges of Roche maintaining a supply network for a global influenza pandemic response initiative based on its antiviral drug Tamiflu.... View Details
Keywords: Martha Lagace
- 22 Apr 2008
- First Look
First Look: April 22, 2008
Business Harvard Business School Case 608-136 Novartis is a science-based drug company, which has important implications for its business strategy. It is one of the largest pharmaceutical companies in the world with over $38B in sales in... View Details
Keywords: Martha Lagace